// App-Quantinova.ai

: A Predefined Analysis from the DECLARE-TIMI 58 Randomised, Placebo-Controlled Trial

Researchers

Presenter

  • ITAMAR RAZ

Principal Investigators

  • STEPHEN D. WIVIOTT

  • ILAN YANUV

  • ALIZA ROZENBERG

  • THOMAS A. ZELNIKER

  • AVIVIT CAHN

  • HIDDO L. HEERSPINK

  • JAMIE P. DWYER

  • ERICA GOODRICH

  • DEEPAK L. BHATT

  • LAWRENCE A. LEITER

  • DARREN K. MCGUIRE

  • JOHN P. WILDING

  • INGRID ANNA GAUSE-NILSSON

  • MARTIN FREDRIKSSON

  • PETER A. JOHANSSON

  • ANNA MARIA LANGKILDE

  • MARC S. SABATINE

Medical Centers

  • N/A

Locations

  • United States

  • Israel

  • Netherlands

  • Canada

  • United Kingdom

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Albuminuria

  • Coronary Artery Disease

  • Type 2 diabetes mellitus

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved